| Page 1441 | Kisaco Research
 

Tom Zuber

Managing Partner
Zuber Lawler

Tom Zuber is a founder and the Managing Partner of Zuber Lawler. Tom is the relationship partner for some 10 Fortune 500 Company clients of the firm, as well as funds and government entities. He has also represented leading cannabis companies for 15 years. Zuber Lawler as a firm manages the highest-stakes matters of a large percentage of the biggest brands in global cannabis. Tom is also a founder of the international cannabis consulting company Global Go. He earned a J.D.

Tom Zuber

Managing Partner
Zuber Lawler

Tom Zuber

Managing Partner
Zuber Lawler

Tom Zuber is a founder and the Managing Partner of Zuber Lawler. Tom is the relationship partner for some 10 Fortune 500 Company clients of the firm, as well as funds and government entities. He has also represented leading cannabis companies for 15 years. Zuber Lawler as a firm manages the highest-stakes matters of a large percentage of the biggest brands in global cannabis. Tom is also a founder of the international cannabis consulting company Global Go. He earned a J.D. degree Columbia Law School, a master s in public policy degree from Harvard University, and a biomedical engineering degree from Rutgers University, where he graduated with highest honors.

 

Bethany Gomez

Managing Director
Brightfield Group

Bethany's core responsibility is to manage Brightfield Group's growing team and drive new product development. She is a key driver of business development, managing some of Brightfield's top clients to ensure long-term success. Her passion for the CBD and cannabis industries helps drive Brightfield's team forward and deliver comprehensive and data-driven answers for each of their customers. She has an extensive background in quantitative research, global policy, and strategic planning.

Bethany Gomez

Managing Director
Brightfield Group

Bethany Gomez

Managing Director
Brightfield Group

Bethany's core responsibility is to manage Brightfield Group's growing team and drive new product development. She is a key driver of business development, managing some of Brightfield's top clients to ensure long-term success. Her passion for the CBD and cannabis industries helps drive Brightfield's team forward and deliver comprehensive and data-driven answers for each of their customers. She has an extensive background in quantitative research, global policy, and strategic planning. Prior to starting Brightfield Group, Bethany managed market research of key CPG industries in Latin America with Euromonitor International.

 

Dr. Claude Kaplan

Director of Commercial Relations
Hatch Innovation Services (HIS)

Dr Claude Kaplan has over 20 years’ experience on the identification, evaluation and exploitation of novel agritech innovations and intellectual property. Previous roles have included; director of an IP commercialisation consultancy, animal & aquaculture health investment specialist for government and head of IP commercialisation for an international aquaculture company. Claude is currently the Director of Commercial Relations, Hatch Innovation Services (HIS).

Dr. Claude Kaplan

Director of Commercial Relations
Hatch Innovation Services (HIS)

Dr. Claude Kaplan

Director of Commercial Relations
Hatch Innovation Services (HIS)

Dr Claude Kaplan has over 20 years’ experience on the identification, evaluation and exploitation of novel agritech innovations and intellectual property. Previous roles have included; director of an IP commercialisation consultancy, animal & aquaculture health investment specialist for government and head of IP commercialisation for an international aquaculture company. Claude is currently the Director of Commercial Relations, Hatch Innovation Services (HIS). HIS, part of HATCH group - a global catalyst for aquaculture innovation, provides support and assistance to companies, governments and researchers in the sourcing, management and commercialisation of aquaculture technologies.

 

Nathan Pyne-Carter

CEO
Ace Aquatec Ltd

Nathan Pyne-Carter received a BA Hons from Clare College, Cambridge University. He took over running of the family business in 2012 where he quickly grew the business through two investment rounds (AquaSpark and 4J Studios), with central office at the Water’s Edge in Dundee, and regional offices in Chile, Norway, Canada and Australia. Current headcount in the company stands at twenty-six with rapid expansion planned for 2021.

Nathan Pyne-Carter

CEO
Ace Aquatec Ltd

Nathan Pyne-Carter

CEO
Ace Aquatec Ltd

Nathan Pyne-Carter received a BA Hons from Clare College, Cambridge University. He took over running of the family business in 2012 where he quickly grew the business through two investment rounds (AquaSpark and 4J Studios), with central office at the Water’s Edge in Dundee, and regional offices in Chile, Norway, Canada and Australia. Current headcount in the company stands at twenty-six with rapid expansion planned for 2021. He has been an invited speaker keynote speaker at industry events such as Oceanology, HavExpo and Seafood Expo North America, as well as winner of the Tayside and Fife IOD, Regional Director of the Year Award in 2020, National Director of the Year for Innovation winner in 2019, and Courier Business award winning Entrepreneur of the Year in 2019. He spearheads a creative look at problems in aquaculture and award-winning innovations span unique in-water electric stunning systems for fish, environmentally responsible acoustic deterrents, 3D biomass camera systems, and lice removal technology for fish.

 

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.  Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.

 

Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.